CTNNA1 and acute myeloid leukemia: In five newly diagnosed AML patients with CTNNA1 hypermethylation, the promoter of the CTNNA1 gene was confirmed by bisulfite sequencing with methylation rates of 91.7%, 92.2%, 93.9%, 93.7% and 91.7%, respectively (Figure 2).